Research programme: antibacterials - AlamX

Drug Profile

Research programme: antibacterials - AlamX

Alternative Names: Antibacterials research programme - AlamX; Beta-lactamase inhibitors - AlamX

Latest Information Update: 23 Aug 2006

Price : $50

At a glance

  • Originator AlamX LLC
  • Class
  • Mechanism of Action Beta lactamase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 23 Aug 2006 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
  • 18 Aug 2000 Preclinical development for Bacterial infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top